Related Experiment Video
Updated: Jun 20, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
RANK(L) as a key target for controlling bone loss
Andreas Leibbrandt1, Josef M Penninger
1Institute of Molecular Biotechnology of the Austrian, Academy of Sciences, Vienna, Austria.
Abstract:
Bone-related diseases, such as osteoporosis or rheumatoid arthritis, affect hundreds of millions of people worldwide and pose a tremendous burden to health care. By deepening our understanding of the molecular mechanisms of bone metabolism and bone turnover, it became possible over the past years to devise new and promising strategies for treating such diseases. In particular, three molecules, the receptor activator of NF-kappaB(RANK), its ligand RANKL and the decoy receptor of RANKL, osteoprotegerin (OPG), attracted the attention of scientists and pharmaceutical companies alike. Genetic experiments evolving around these molecules established their pivotal role as central regulators of osteoclast function. RANK-RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also fine-tunes bone homeostasis both in normal physiology and disease. Consequently, novel drugs specifically targeting RANK-RANKL and their signaling pathways in osteoclasts are expected to revolutionize the treatment of various ailments associated with bone loss, such as arthritis, cancer metastases, or osteoporosis.
Insights
Understanding bone metabolism through key molecules like RANK, RANKL, and OPG offers new treatments for bone diseases. Targeting RANK-RANKL signaling in osteoclasts can revolutionize therapies for osteoporosis and arthritis.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Bone-related diseases like osteoporosis and rheumatoid arthritis impact millions globally.
- Understanding molecular mechanisms of bone metabolism is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of receptor activator of NF-kappaB (RANK), its ligand RANKL, and osteoprotegerin (OPG) in bone metabolism.
- To explore the potential of targeting the RANK-RANKL signaling pathway for treating bone loss conditions.
Main Methods:
- Genetic experiments focusing on RANK, RANKL, and OPG.
- Analysis of downstream signaling pathways involved in osteoclast function.
- Investigating the crosstalk between signaling pathways in bone homeostasis.
Main Results:
- Established the pivotal role of RANK, RANKL, and OPG as central regulators of osteoclast function.
- Demonstrated that RANK-RANKL signaling activates pathways essential for osteoclast development.
- Highlighted the fine-tuning of bone homeostasis through signaling crosstalk.
Conclusions:
- Targeting RANK-RANKL signaling pathways in osteoclasts presents a promising therapeutic strategy.
- Novel drugs targeting this pathway are expected to revolutionize the treatment of bone loss disorders.
- This research advances the understanding of bone metabolism for treating osteoporosis, arthritis, and cancer metastases.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Skeleton and Calcium Homeostasis